Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
58.89
+0.09 (0.16%)
Apr 26, 2024, 2:47 PM EDT - Market open
Exact Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 605.38 | 242.49 | 315.47 | 1,491 | 177.25 | 160.43 | 77.49 | 48.92 | 41.14 | 58.13 | Upgrade
|
Short-Term Investments | 172.27 | 389.56 | 715.01 | 348.7 | 146.4 | 963.75 | 347.22 | 262.18 | 265.74 | 224.63 | Upgrade
|
Cash & Cash Equivalents | 777.64 | 632.06 | 1,030 | 1,840 | 323.66 | 1,124 | 424.72 | 311.1 | 306.88 | 282.76 | Upgrade
|
Cash Growth | 23.03% | -38.66% | -44.00% | 468.50% | -71.21% | 164.69% | 36.52% | 1.38% | 8.53% | 112.19% | Upgrade
|
Receivables | 203.62 | 158.04 | 216.65 | 233.19 | 130.36 | 45.33 | 26.42 | 8.53 | 4.93 | 1.38 | Upgrade
|
Inventory | 127.48 | 118.26 | 104.99 | 92.27 | 61.72 | 39.15 | 26.03 | 6.83 | 6.68 | 4.02 | Upgrade
|
Other Current Assets | 85.63 | 73.9 | 74.12 | 33.16 | 38.2 | 19.41 | 10.06 | 7.11 | 7.38 | 3.53 | Upgrade
|
Total Current Assets | 1,194 | 982.26 | 1,426 | 2,199 | 553.94 | 1,228 | 487.22 | 333.57 | 325.86 | 291.68 | Upgrade
|
Property, Plant & Equipment | 842.06 | 851.76 | 754.47 | 577.93 | 581.77 | 245.26 | 79.99 | 38.14 | 34.1 | 19.95 | Upgrade
|
Goodwill and Intangibles | 4,258 | 4,302 | 4,430 | 2,085 | 2,347 | 46.28 | 24.21 | 1.55 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 177.39 | 90.58 | 74.59 | 63.77 | 23.32 | 4.42 | 7.15 | 3.78 | 4.07 | 1.2 | Upgrade
|
Total Long-Term Assets | 5,277 | 5,245 | 5,259 | 2,726 | 2,952 | 295.96 | 111.34 | 43.47 | 38.17 | 21.15 | Upgrade
|
Total Assets | 6,471 | 6,227 | 6,685 | 4,925 | 3,506 | 1,524 | 598.56 | 377.04 | 364.03 | 312.82 | Upgrade
|
Accounts Payable | 78.82 | 74.92 | 67.83 | 35.71 | 25.97 | 28.14 | 16.14 | 0.71 | 3.31 | 2.65 | Upgrade
|
Current Debt | 79.38 | 28.37 | 19.71 | 325.52 | 8.73 | 0.01 | 0.18 | 0.17 | 0.17 | 0.36 | Upgrade
|
Other Current Liabilities | 356.51 | 309.47 | 429.53 | 271.87 | 201.8 | 108.02 | 51.81 | 29.81 | 23.25 | 14.51 | Upgrade
|
Total Current Liabilities | 514.7 | 412.75 | 517.07 | 633.1 | 236.49 | 136.17 | 68.12 | 30.69 | 26.72 | 17.52 | Upgrade
|
Long-Term Debt | 2,475 | 2,419 | 2,362 | 2,005 | 946.3 | 689.24 | 4.27 | 4.63 | 4.79 | 1 | Upgrade
|
Other Long-Term Liabilities | 335.98 | 352.46 | 417.78 | 51.34 | 34.91 | 17.67 | 5.75 | 6.42 | 5.66 | 5.32 | Upgrade
|
Total Long-Term Liabilities | 2,811 | 2,771 | 2,780 | 2,056 | 981.21 | 706.91 | 10.02 | 11.05 | 10.45 | 6.32 | Upgrade
|
Total Liabilities | 3,326 | 3,184 | 3,297 | 2,690 | 1,218 | 843.08 | 78.14 | 41.75 | 37.17 | 23.84 | Upgrade
|
Total Debt | 2,555 | 2,447 | 2,382 | 2,331 | 955.03 | 689.25 | 4.45 | 4.81 | 4.96 | 1.36 | Upgrade
|
Debt Growth | 4.41% | 2.72% | 2.21% | 144.04% | 38.56% | 15385.31% | -7.41% | -2.99% | 264.34% | -20.51% | Upgrade
|
Retained Earnings | -3,469.18 | -3,265.03 | -2,641.52 | -2,045.9 | -1,119.76 | -1,035.76 | -860.61 | -745.82 | -578.61 | -420.81 | Upgrade
|
Comprehensive Income | 1.43 | -5.24 | -1.44 | 0.53 | -0.1 | -1.42 | -0.75 | -0.42 | -0.43 | -0.12 | Upgrade
|
Shareholders' Equity | 3,145 | 3,043 | 3,388 | 2,236 | 2,288 | 680.94 | 520.42 | 335.3 | 326.86 | 288.98 | Upgrade
|
Net Cash / Debt | -1,777.08 | -1,814.81 | -1,351.63 | -490.63 | -631.37 | 434.93 | 420.26 | 306.29 | 301.92 | 281.4 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | 3.49% | 37.21% | 1.45% | 7.30% | 113.91% | Upgrade
|
Net Cash Per Share | -9.86 | -10.29 | -7.89 | -3.25 | -4.81 | 3.56 | 3.63 | 2.99 | 3.28 | 3.51 | Upgrade
|
Working Capital | 679.67 | 569.51 | 909.17 | 1,565 | 317.44 | 1,092 | 419.09 | 302.88 | 299.14 | 274.16 | Upgrade
|
Book Value Per Share | 17.46 | 17.26 | 19.77 | 14.79 | 17.43 | 5.57 | 4.50 | 3.28 | 3.55 | 3.60 | Upgrade
|